BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s.: Advancing Veterinary Medicine Through Research & Innovation
About BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s.
BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s. is a Czech-based research institute and manufacturer specializing in veterinary pharmaceuticals and biopharmacy. Established in the Czech Republic, BIOPHARM is dedicated to the development, production, and quality assurance of veterinary drugs, vaccines, and feed additives.
With a strong emphasis on scientific research, the company plays a pivotal role in advancing veterinary medicine, particularly in the prevention and treatment of livestock and poultry diseases. Its flagship LIVACOX® series of live attenuated vaccines is globally recognized for coccidiosis prevention in poultry farming.
Core Business and Market Positioning
BIOPHARM operates at the intersection of biopharmaceutical research, veterinary medicine, and animal health innovation, offering:
- Veterinary vaccines and pharmaceuticals for disease prevention and treatment.
- Research-based solutions for farm and companion animals.
- Collaborations with global veterinary institutions to advance vaccine and drug development.
BIOPHARM is a recognized leader in poultry health solutions, with a strong market presence across Europe, Asia, and Latin America.
Product and Service Offerings
Veterinary Vaccines
BIOPHARM is best known for its LIVACOX® series of live attenuated vaccines, designed for the prevention of coccidiosis in poultry. Key vaccine offerings include:
- LIVACOX® Q – Designed for broiler chickens, ensuring broad-spectrum coccidiosis immunity.
- LIVACOX® T – Developed for layer hens and breeding stock, providing long-term protection.
- LIVACOX® C – A specialized vaccine for turkeys, targeting species-specific coccidial infections.
Veterinary Medicines & Feed Additives
BIOPHARM produces a range of veterinary drugs, feed additives, and nutritional supplements, ensuring optimal animal health, growth, and performance.
Research & Development Leadership
BIOPHARM is at the forefront of veterinary biopharmaceutical research, investing heavily in:
- Development of innovative vaccines for disease prevention in livestock and poultry.
- Pharmacokinetics and bioavailability studies to improve veterinary drug formulations.
- International collaborations with universities and veterinary institutions for research-driven advancements in animal health.
Market Expansion & Global Presence
- Strong footprint in Europe, with expanding vaccine distribution in Asia and Latin America.
- Trusted by poultry producers worldwide for its coccidiosis vaccine solutions.
- Strategic research partnerships with leading veterinary and pharmaceutical organizations.
Certifications & Compliance
BIOPHARM adheres to strict international veterinary regulations, ensuring:
- GMP-certified production facilities for vaccine and pharmaceutical manufacturing.
- Compliance with EU and global veterinary pharmaceutical standards.
- Quality control measures backed by extensive research and testing.
Customer Testimonials & Industry Recognition
- Recognized as a pioneer in poultry vaccine innovation, particularly in coccidiosis prevention.
- Endorsed by leading poultry producers and veterinarians worldwide for its LIVACOX® vaccines.
- Awarded for excellence in veterinary research and pharmaceutical innovation.
Major Achievements
- Global leader in coccidiosis vaccine development, with widespread adoption of LIVACOX® vaccines.
- Successful expansion into Asian and Latin American poultry markets.
- Continuous investment in biopharmaceutical research, contributing to advancements in animal health.
- Trusted partner for veterinary professionals and livestock producers seeking science-backed solutions.
BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s. remains at the forefront of veterinary medicine, delivering innovative, research-driven solutions that enhance global animal health and food production efficiency.